Bio-Techne Corp (NASDAQ:TECH)
| 351.42 BATS BZX Real-Time Price As of 2:52pm ET |  -10.07 / -2.79%Today’s Change | 155.17 Today|||52-Week Range 414.99 | +10.67% Year-to-Date |
Latest TECH News | Press Releases
No recent news for Bio-Techne Corp.
Today’s Trading
| Previous close | 361.49 |
| Today’s open | 361.84 |
| Day’s range | 346.39 - 361.98 |
| Volume | 9,465 |
| Average volume (3 months) | 178,796 |
| Market cap | $14.0B |
Data as of 2:52pm ET, 03/04/2021
Growth & Valuation
| Earnings growth (last year) | +136.07% |
| Earnings growth (this year) | +35.03% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | +3.46% |
| P/E ratio | 79.9 |
| Price/Sales | 14.09 |
| Price/Book | 10.06 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BMRNBiomarin Pharmaceuti... | +0.11 | +0.14% |
| NVAXNovavax Inc | -20.78 | -11.32% |
| ZLABZai Lab Ltd | -4.25 | -3.02% |
| CRSPCRISPR Therapeutics ... | -4.24 | -3.56% |
Data as of 2:55pm ET, 03/04/2021
Financials
| Next reporting date | May 4, 2021 |
| EPS forecast (this quarter) | $1.55 |
| Annual revenue (last year) | $738.7M |
| Annual profit (last year) | $229.1M |
| Net profit margin | 31.01% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Minneapolis, Minnesota |
Forecasts
